BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6185150)

  • 1. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
    Lasson A; Ohlsson K
    Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
    Lasson A; Dittmann B; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the human pancreatic secretory trypsin inhibitor on trypsin-induced C3 and kininogen cleavage: an in vitro study.
    Ohlsson K
    Scand J Gastroenterol Suppl; 1986; 126():18-20. PubMed ID: 2436281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin-release in vitro and in vivo. Protease inhibitors and trypsin-induced bradykinin release.
    Balldin G; Gustafsson EL; Ohlsson K
    Eur Surg Res; 1980; 12(4):260-9. PubMed ID: 6166477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.
    Balldin G; Eddeland A; Ohlsson K
    Scand J Gastroenterol; 1981; 16(5):603-9. PubMed ID: 6172839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
    Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trasylol prevents trypsin-induced shock in dogs.
    Balldin G; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):651-6. PubMed ID: 89067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro.
    Balldin G; Ohlsson K; Olsson AS
    Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):691-7. PubMed ID: 307526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of alpha 2-macroglobulin and aprotinin.
    Ohlsson F; Balldin G; Lasson A
    Adv Exp Med Biol; 1983; 156 (Pt B)():1083-90. PubMed ID: 6190382
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
    Balldin G; Borgström A; Genell S; Ohlsson K
    Res Exp Med (Berl); 1983; 183(3):203-13. PubMed ID: 6196821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of peptide hormones by alpha 2-macroglobulin-trypsin complex and its relation to the pathogenesis and chemotherapy of acute pancreatitis.
    Hermon-Taylor J; Magee AI; Grant DA; Jones PA; Marshall CE; Dunham J
    Clin Chim Acta; 1981 Jan; 109(2):203-9. PubMed ID: 6162593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions in vitro and in vivo between anionic and cationic porcine trypsin and porcine plasma proteinase inhibitors.
    Hjelmqvist B; Borgström A; Ohlsson K
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1331-6. PubMed ID: 3242553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interaction of porcine serum and colostrum protease inhibitors with pancreatic trypsin, chymotrypsin and elastase.
    Ohlsson BG; Weström BR; Karlsson BW
    Biochim Biophys Acta; 1982 Aug; 705(3):357-65. PubMed ID: 6181813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
    Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment.
    Lasson A
    Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions in vitro and in vivo between rat serum protease inhibitors and anodal and cathodal rat trypsin and chymotrypsin.
    Gauthier F; Genell S; Mouray H; Ohlsson K
    Biochim Biophys Acta; 1979 Jan; 566(1):200-10. PubMed ID: 83164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions in vitro and in vivo between human and porcine cationic pancreatic elastase and plasma protease inhibitors.
    Håkansson HO; Ohlsson K
    Biol Chem Hoppe Seyler; 1988 Apr; 369(4):309-15. PubMed ID: 2456771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the interaction of human cationic trypsin with serum protease inhibitors (author's transl)].
    Iwaki K; Ogawa M; Kitahara T; Tanaka S; Kosaki G
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):276-81. PubMed ID: 6178863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.